In Health & Care, Gimv is investing in pioneering biotechnology, innovative medical technology and leading service companies in the health & care sector.
Covid-19 once again proved the importance of a well-functioning health care system. The pandemic placed huge pressure on hospitals and medical staff, on top of all the other health challenges we see in society. Our population is ageing. People are living longer and more chronically ill people need help. The government must meet the challenges in the health and care sector with a budget that - this year more than ever - is under pressure. Fortunately, technological innovations and scientific progress are progressing. New vaccines, diagnoses and treatments are appearing and the available resources are used as efficiently as possible to achieve results.
The investment opportunities in the sector are great. The Health & Care platform’s experienced team has long been familiar with the entire life cycle of a company and invests throughout the value chain. As one of the Europe’s most active healthcare investors, Gimv is keen to make a positive contribution to the United Nations’ sustainable development goals for health and well-being.
Health & Care Services
Life Sciences Advisory Board
The Gimv Life Sciences Advisory Board consists of 6 seasoned industry veterans with expertise in drug- and medtech development, company building and M&A. They will assist the Gimv Life Sciences team with portfolio development, deal sourcing and assessing general industry trends.